AOZORA Study: Interim Analysis of Joint Health in Children with Hemophilia A, without FVIII Inhibitors, 3 Years after Initiating Emicizumab
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:2742-2744 - Subject
- Language
- ISSN
- 0006-4971